()
Share Price News & Updates

Biotech stock Mesoblast [ASX:MSB] plunged 12% on Tuesday after updating the market on a second class action lawsuit lodged against it.

Biotech company Mesoblast [ASX:MSB] released its third quarter results today with MSB shares trading down following the update.